Molecular marker miR-147a of breast cancer

The invention provides a molecular marker miR-147a of breast cancer and use thereof in a diagnostic reagent for diagnosing breast caner. Content of miR-147a in serum of breast cancer patient is raised compared with that of a normal person. After the patient receives operation, the content of miR-147...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LI TONGEN, LI QIJING, LI SHIYOU
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a molecular marker miR-147a of breast cancer and use thereof in a diagnostic reagent for diagnosing breast caner. Content of miR-147a in serum of breast cancer patient is raised compared with that of a normal person. After the patient receives operation, the content of miR-147a in serum falls back to normal level. The invention further provides a diagnostic reagent kit for diagnosing breast caner. By utilizing the molecular marker miR-147a of breast cancer to diagnose breast caner, the characteristics of simplicity in operation, conveniently-obtained materials, safety, no invasiveness, high specific, high sensitivity and easiness for screening in a large scale are achieved.